Angiology · 1994 · 12 citations · 1 references
MedicineHematologySurgeryHemostasisOrthopedicsVascular SurgeryAnticoagulant TherapyAntithrombotic TherapyDeep Vein ThrombosisThromboembolic DiseaseThrombolytic TherapyThrombosisArterial Occlusion ManagementBlood FlowClot Lysis TherapyDistal Deep Vein ThrombosisIntrapleural Fibrinolytic TherapyIntravenous Tissue Plasminogen ActivatorIsolated Prolonged Activated Partial Thromboplastin TimeSystemic Thrombolysis
Lysis block treatment (LBT) is a new form of fibrinolytic therapy for deep vein thrombosis and arterial occlusion in the distal parts of the limbs. Strictly local lysis was achieved by placing a cuff around the thigh or the upper arm, inflating the cuff to a pressure of 500 mmHg ("Bier's blockade"), and giving heparin and tissue plasminogen activator (rt-PA) by intravenous injection into the dorsal pedis or antecubital veins. Occlusion lasted for one hour. This new technique was demonstrated in 22 patients. Six patients presented with popliteal vein thromboses and 1 patient with a distal femoral vein thrombosis. In addition, 15 arterial occlusions were treated comprising 3 calf, 6 popliteal, 3 distal femoral, and 2 digital sites and 1 brachial site. Five of 7 venous and 9 of 15 arterial occlusions were partially or totally removed. The activated partial thromboplastin time remained nearly unchanged during LBT and only a limited and short-term lengthening was recorded after restoration of blood flow. This was of importance for patients with bleeding tendencies, which are normally a contraindication for systemic lysis. LBT may therefore be considered as a useful alternative to systemic fibrinolytic treatment.
1